<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a 59 years old patient suffering from a non stenotic atheroma of the internal right carotid artery, 12 attacks of "<z:hpo ids='HP_0100576'>amaurosis fugax</z:hpo>" (a.m.) affecting the right eye occurred over a period of 36 days </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="9588">Ticlopidine</z:chebi> at doses of 500 mg and subsequently of 250 mg per day was administered and the attacks of "<z:hpo ids='HP_0100576'>amaurosis fugax</z:hpo>" briskly stopped </plain></SENT>
<SENT sid="2" pm="."><plain>In the 8 month period following the occurrence of the last episode of monocular <z:hpo ids='HP_0000618'>blindness</z:hpo>, the patient continued the therapy with <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> and no visual disturbances were more reported </plain></SENT>
<SENT sid="3" pm="."><plain>The most likely pathogenetic hypotheses of "<z:hpo ids='HP_0100576'>amaurosis fugax</z:hpo>" in the present case are discussed as well as the possibility that the relation between the attacks of a.m. and the beginning of the treatment with <z:chebi fb="0" ids="9588">ticlopidine</z:chebi> might be fortuitous </plain></SENT>
</text></document>